HEALTH● LOW1h ago · Oct 5, 2026, 11:44 AM
FDA approves additional U.S. manufacturing capacity for Simlandi, Alvotech’s biosimilar to Humira
Seeking Alpha Tech · north america
The FDA has approved expanded manufacturing capacity in the U.S. for Simlandi, Alvotech's biosimilar to Humira. This approval aims to increase the availability of the drug.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH37m ago'Situation under control' say Russian authorities after reports of plague in SiberiaEuroNews [en]HEALTH43m agoWatch live: RFK Jr., Trump officials unveil health care price transparency pushThe HillHEALTH50m agoPublic apprehension over unnecessary medical procedures should not delay treatment, say cardiologists in KeralamThe HinduHEALTH1h agoExtreme heat is raising risks for mothers and babies - but experts say cooling solutions already existEuroNews [en]